Anti-inflammatory effects of beraprost sodium, a stable analogue of PGI2, and its mechanisms

Prostaglandins

Volumn 53, Issue 4, 1997, Pages 279-289

  Ueno, Yuji ^a   Koike, Hiroshi ^a   Annoh, Shigeyasu ^a   Nishio, Shintaro ^a  

^a TORAY INDUSTRIES INC   (Japan)

Author keywords

5 HT induced edema; Anti inflammatory effect; Beraprost sodium; Lung edema and ventricular hypertrophy; Prostaglandin E1; Pulmonary thromboembolism

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; BERAPROST; COLLAGEN; PROSTAGLANDIN E1; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD VESSEL PERMEABILITY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENCY; HEART VENTRICLE HYPERTROPHY; LUNG EDEMA; LUNG EMBOLISM; MALE; MOUSE; NONHUMAN; PAW EDEMA; RAT;

ANIMALIA;

EID: 0030990539     PISSN: 00906980     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-6980(97)89601-3     Document Type: Article

References (26)

1. Furie, M.B., Cramer, E.B., Naprstek, B.L., and Silverstein, S.C. Cultured endothelial cell monolayers that restrict the transendothelial passage of macromolecules and electrical current. J. Cell Biol., 98: 1033-1041, 1984.
2. Warren, J.B., Wilson, A.J., Loi, R.K., and Coughlan, M.L. Opposing roles of cyclic AMP in the vascular control of edema formation. FASEB J., 7: 1394-1400, 1993.
3. Hopkins, N.K., and Gorman, R.R. Regulation of endothelial cell cyclic nucleotide metabolism by prostacyclin. J. Clin. Invest., 67: 540-546, 1981.
4. 2 as a potentiator of acute inflammation in rats. Prostaglandins, 15: 557-564, 1978.
5. 2 and the vascular changes of inflammation. Br. J. Pharmacol., 65: 517-524, 1979.
6. 2 derivatives and their inhibitory activities to human platelet aggregation. Adv. Prostaglandin Thromboxane Leukotriene Res., 15: 279-281, 1985.
7. 2 analogue. Jpn. J. Pharmacol., 43:81-89, 1987.
8. Nishio, S., Matsuura, H., Kanai, N., Fukatsu, Y., Hirano, T., Nishikawa, N., Kameoka, K., and Umetsu, T. The in vivo and ex vivo anti-platelet effect of TRK-100, a stable prostacyclin analog, in several species. Jpn J Pharmacol 47: 1-9, 1988.
9. Sim, A.K., McCraw, A.P., Cleland, M.E., Nishio, S., and Umetsu, T. Effects of a stable prostacyclin analogue on platelet function and experimentally-induced thrombosis in the microcirculation. Arzneim-Forsch/Drug Res., 35: 1816-1818, 1985.
10. Ueno, Y., Kawashima, A., Koike, H., and Nishio, S. Effect of beraprost sodium, a stable prostacyclin analogue, on pulmonary thromboembolism in mice. Thromb. Res., 77: 193-198, 1995.
11. 2 analogue. Br. J. Pharmacol., 89: 703-711, 1986.
12. Kainoh, M., Maruyama, I., Nishio, S., and Nakadate, T Enhancement by beraprost sodium, a stable analogue of prostacyclin, in thrombomodulin expression on membrane surface of cultured vascular endothelial cells via increase in cyclic AMP level. Biochem. Pharmacol., 41: 1135-1140, 1991.
13. Fulton, R.M., Hutchinson, E.G., Jones, A.M. Ventricular weight in cardiac hypertrophy. Br. Heart J., 14: 413-420, 1952.
14. Miyata, M., Ueno, Y., Sekine, H., Ito, O., Sakuma, F., Koike, H., Nishio, S., Nishimaki, T., and Kasukawa, R. Protective effect of beraprost sodium, a stable prostacyclin analogue, in development of monocrotaline-induced pulmonary hypertension. J. Cardiovasc Pharmacol., 27: 20-26, 1996.
15. Kainoh, M., Ueno, S., Endoh, T., and Nakadate, T. Inhibitory effect of beraprost sodium on formation of lipid peroxides in ischemia and recirculation-induced cerebral injury. Pharmacol. Res., 28: 249-258, 1993.
16. Williams, T.J. Interaction between prostaglandins, leukotriens and other mediators of inflammation. Br. Med. Bull., 39: 239-242, 1983.
17. Casnocha, S.A., Eskin, S.G., Hall, E.R., and Mcintire, L.V. Permiability of human endothelial monolayers: effect of vasoactive agonists and cAMP. J. Appl. Physiol., 67: 1997-2005, 1989.
18. Langeler, E.G., and Van Hinsbergh, V.W.M. Norepinephrine and iloprost improve barrier function of human endothelial monolayers: role of cAMP. Am. J. Physiol., 260: C1052-1059, 1990.
19. Plaut, M., Marone, G., Thomas, L.L., and Lichtenstein, L.M. In: Advances in Cyclic Nucleotides Research. Cyclic nucleotides in immune responses and allergy. (P. Hamet and H. Sands, eds.) Ravan Press, New York. 1980, p. 161-172.
20. Kainoh, M., Imai, R., Umetsu, T., Hattori, M., and Nishio, S. Prostacyclin and beraprost sodium as suppressors of activated rat polymorphnuclear leukocytes. Biochem. Pharmacol., 39: 477-483, 1990.
21. Seeger, W., Wolf, H., Stahler, G., Neuhof, H., and Roka, L. Increased pulmonary vascular resistance and permeability due to arachidonate metabolism in isolated rabbit lungs. Prostaglandins, 23: 157-173, 1982.
22. Morel, N.M., Petruzzo, P.P., Hechtman, H.B., and Shepro, D. Inflammatory agonists that increase microvascular permeability in vivo stimulate cultured pulmonary microvessel endothelial cell contraction. Inflammation, 14: 571-583, 1990.
23. Minnear, F.L., Demichele, M.A.A., Moon, D.G., Rieder, C.L., and Fenton II, J.W. Isoproterenol reduces thrombin-induced pulmonary endothelial permeability in vitro. Am. J. Physiol., 26: H1613-1623, 1989.
24. Mizuno-Yagyu, Y., Hashida, R., Mineo, C., Ikegami, S., Ohkuma, S., and Takano, T. Effect of PGI2 on transcellular transport of fluorescein dextran through an arterial endothelial monolayer. Biochem. Pharmacol., 22: 3809-3813, 1987.
25. Imai-Sasaki, R., Kainoh, M., Ogawa, Y., Ohmori, E., Asai, Y., and Nakadate, T. Inhibition by beraprost sodium of thrombin-induced increase in endothelial macromolecular permeability. Prostaglandins Leukot. Essent. Fatty Acids, 53: 103-108, 1995.
26. 1 cause breakdown of the blood-retinal barrier by opening tight junctions between vascular endothelial calls. Invest. Ophthalmol. Vis. Sci., 33: 1870-1878, 1992.